drugset / Trial / NCT02212795
Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin
RandomizedCrossoverOpen-labelHealth-services research
Summary
Phase I clinical study to compare the pharmacokinetic profiles and bactericidal activity of Zabofloxacin 183mg, 367mg and Levofloxacin 250mg after oral administration in healthy volunteer
Timeline
- Start
- 2014-05
- Primary completion
- 2014-08
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levofloxacin | Small molecule | 250 mg | Oral |
| Subject | Zabofloxacin | Small molecule | 183 mg | Oral |
| Subject | Zabofloxacin | Small molecule | 367 mg | Oral |
Indications
No indication recorded.